Exploristics offer analysis tools to identify and exploit opportunities for Pharmacogenetics.
There is increasing demand in the Pharmaceutical industry, in medical practice and by Regulatory Authorities to use new data, such as genetics, to identify patients who are likely to respond to treatment. At present, there are relatively few examples of the successful application of these data. This paper proposes some practical solutions to overcome the limitations of common applications.
Exploristics have implemented tools that can help improve the identification of predictive factors and their integration into clinical development. These tools can be applied at a study or portfolio level and enable a cost effective, informed and pragmatic approach to the use of genetics and other predictors.